Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

(Ivanhoe Newswire) — Women undergoing chemotherapy for breast cancer often face many side effects. One ... a commonly used drug called Taxotere or Docetaxel, has significantly less neuropathy ...

Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

Analysts at Leerink Partners said in a Monday note that DESTIN-Breast09’s findings “could support an approval” for Enhertu in ...

Lead investigational program, NDV-01, for High-Grade Non-Muscle Invasive Bladder Cancer, is being evaluated in a Phase 2 study. In addition, preparations are underway to advance sepranolone, a Phase ...

Lead investigational program, NDV-01, for High-Grade Non-Muscle Invasive Bladder Cancer, is being evaluated in a Phase 2 study. In addition, preparations are underway to advance sepranolone, a Phase ...

NDV-01 is a novel, investigational, sustained-release gemcitabine/docetaxel formulation, designed as a ready-for-use intravesical therapy for the treatment of NMIBC. The U.S. prevalence of NMIBC is ...

On March 25th, we announced an exclusive licensing agreement with Trigone Pharma Limited for NDV-01, a novel sustained release intravascular chemotherapy ... reduce side effects and reduce the ...

The latest setback is in a phase 3 trial of MSD's anti-TIGIT antibody vibostolimab and PD-1 inhibitor pembrolizumab in small cell lung cancer (SCLC), with a lack of efficacy and side effects both ...

Greetings and welcome to the Relmada Therapeutics Incorporated quarter four 2024 financial results call. Good day, everyone and thank you for joining us today. This afternoon, Relmada issued a press ...